BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naeem A, Dakshanamurthy S, Walthieu H, Parasido E, Avantaggiati M, Tricoli L, Kumar D, Lee RJ, Feldman A, Noon MS, Byers S, Rodriguez O, Albanese C. Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient-derived primary prostate cells. Prostate 2020;80:1233-43. [PMID: 32761925 DOI: 10.1002/pros.24050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Naeem A, Choudhry MU, Kroemer A, Wahnschafft S, Cui W, Albanese C. Expansion of human amniotic epithelial cells using condition cell reprogramming technology. Hum Cell 2022. [PMID: 36586053 DOI: 10.1007/s13577-022-00849-4] [Reference Citation Analysis]
2 Naeem A, Gupta N, Naeem U, Khan MJ, Elrayess MA, Cui W, Albanese C. A comparison of isolation and culture protocols for human amniotic mesenchymal stem cells. Cell Cycle 2022;:1-14. [PMID: 35412950 DOI: 10.1080/15384101.2022.2060641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Naeem A, Gupta N, Arzoo N, Naeem U, Khan MJ, Choudhry MU, Cui W, Albanese C. A Survey and Critical Evaluation of Isolation, Culture, and Cryopreservation Methods of Human Amniotic Epithelial Cells. Cell Cycle 2022;:1-19. [PMID: 35289707 DOI: 10.1080/15384101.2021.2020015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Biswas R, Dey A, Puri R, Akermi S, Sahoo S, Panesar R, Jana C, Jayant S, Nigam A, Bernard J, Sinha S, Johari S. Computational Intelligence-Based Cheminformatics Model as Cancer Therapeutics. Computational Intelligence in Oncology 2022. [DOI: 10.1007/978-981-16-9221-5_15] [Reference Citation Analysis]
5 Alkhilaiwi F. Conditionally Reprogrammed Cells and Robotic High-Throughput Screening for Precision Cancer Therapy. Front Oncol 2021;11:761986. [PMID: 34737964 DOI: 10.3389/fonc.2021.761986] [Reference Citation Analysis]
6 Naeem A, Dakshanamurthy S, Walthieu H, Parasido E, Avantaggiati M, Tricoli L, Kumar D, Lee RJ, Feldman A, Noon MS, Byers S, Rodriguez O, Albanese C. Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient-derived primary prostate cells. Prostate 2020;80:1233-43. [PMID: 32761925 DOI: 10.1002/pros.24050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]